ReviewDermatology and therapy2024

A Narrative Review of the OX40-OX40L Pathway as a Potential Therapeutic Target in Atopic Dermatitis: Focus on Rocatinlimab and Amlitelimab.

Asaad Abdelhalim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.